A STAT3–STING–IFN axis controls the metastatic spread of small cell lung cancer

Forman, D. et al. (eds) Cancer Incidence in Five Continents Volume X (IARC, 2014).

Rudin, C. M. et al. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nat. Rev. Cancer 19, 289–297 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gay, C. M. et al. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. Cancer Cell 39, 346–360 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burr, M. L. et al. An evolutionarily conserved function of Polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer. Cancer Cell 36, 385–401 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mahadevan, N. R. et al. Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity. Cancer Discov. 11, 1952–1969 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chan, J. M. et al. Signatures of plasticity, metastasis and immunosuppression in an atlas of human small cell lung cancer. Cancer Cell 39, 1479–1496 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huynh, J., Chand, A., Gough, D. & Ernst, M. Therapeutically exploiting STAT3 activity in cancer—using tissue repair as a road map. Nat. Rev. Cancer 19, 82–96 (2019).

Article  CAS  PubMed  Google Scholar 

Hong, D. et al. AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer. Sci. Transl. Med. 7, 314ra185 (2015).

Article  PubMed  PubMed Central  Google Scholar 

George, J. et al. Comprehensive genomic profiles of small cell lung cancer. Nature 524, 47–53 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Azare, J. et al. Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin β6. Mol. Cell. Biol. 27, 4444–4453 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mollaoglu, G. et al. MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to Aurora kinase inhibition. Cancer Cell 31, 270–285 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen, J. et al. Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium. Oncogene 41, 138–145 (2022).

Article  CAS  PubMed  Google Scholar 

Travis, W. D. Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas. Mod. Pathol. 25, S18–S30 (2012).

Article  CAS  PubMed  Google Scholar 

Nakazawa, K. et al. Specific organ metastases and survival in small cell lung cancer. Oncol. Lett. 4, 617–620 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Denny, S. K. et al. Nfib promotes metastasis through a widespread increase in chromatin accessibility. Cell 166, 328–342 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huntington, N. D., Cursons, J. & Rautela, J. The cancer–natural killer cell immunity cycle. Nat. Rev. Cancer 20, 437–454 (2020).

Article  CAS  PubMed  Google Scholar 

Raz, R., Durbin, J. E. & Levy, D. E. Acute phase response factor and additional members of the interferon-stimulated gene factor 3 family integrate diverse signals from cytokines, interferons and growth factors. J. Biol. Chem. 269, 24391–24395 (1994).

Article  CAS  PubMed  Google Scholar 

Musella, M., Manic, G., De Maria, R., Vitale, I. & Sistigu, A. Type-I-interferons in infection and cancer: unanticipated dynamics with therapeutic implications. Oncoimmunology 6, e1314424 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Dunn, G. P. et al. A critical function for type I interferons in cancer immunoediting. Nat. Immunol. 6, 722–729 (2005).

Article  CAS  PubMed  Google Scholar 

Ishikawa, H., Ma, Z. & Barber, G. N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788–792 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu, C. H. et al. TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS/STING in ALS. Cell 183, 636–649 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sen, T. et al. Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer. Cancer Discov. 9, 646–661 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rusinova, I. et al. Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res. 41, D1040–D1046 (2013).

Article  CAS  PubMed  Google Scholar 

Bidwell, B. N. et al. Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat. Med. 18, 1224–1231 (2012).

Article  CAS  PubMed  Google Scholar 

Zhao, Y. et al. Overexpression of interferon regulatory factor 7 (IRF7) reduces bone metastasis of prostate cancer cells in mice. Oncol. Res 25, 511–522 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Gough, D. J. et al. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 324, 1713–1716 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grabner, B. et al. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis. Nat. Commun. 6, 6285 (2015).

Article  CAS  PubMed  Google Scholar 

Lee, C.-K. et al. Distinct requirements for IFNs and STAT1 in NK cell function. J. Immunol. 165, 3571 (2000).

Article  CAS  PubMed  Google Scholar 

Best, S. A. et al. Harnessing natural killer immunity in metastatic SCLC. J. Thorac. Oncol. 15, 1507–1521 (2020).

Article  CAS  PubMed  Google Scholar 

Glasner, A. et al. NKp46 receptor-mediated interferon-γ production by natural killer cells increases fibronectin 1 to alter tumor architecture and control metastasis. Immunity 48, 107–119 (2018).

Article  CAS  PubMed  Google Scholar 

van der Weyden, L. et al. Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Nature 541, 233–236 (2017).

Article  PubMed 

留言 (0)

沒有登入
gif